Allogeneic Corneal Graft Survival T Cells , and Prolongs + Increases Foxp 3 IDO-Mediated Immune Modulation , Topical Application of Soluble CD 83 Induces

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Suppression of the allogeneic response by the anti‐allergy drug N‐(3,4‐dimethoxycinnamonyl) anthranilic acid results from T‐cell cycle arrest

  2013cited by this paper
• Donor‐derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization‐dominant setting of corneal transplantation

  2012cited by this paper
• Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells

  2011cited by this paper
• 3-hydroxykynurenine suppresses CD4+ T-cell proliferation, induces T-regulatory-cell development, and prolongs corneal allograft survival.

  2011cited by this paper
• Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation

  2010cited by this paper
• Induction of Kidney Allograft Tolerance by Soluble CD83 Associated With Prevalence of Tolerogenic Dendritic Cells and Indoleamine 2,3-Dioxygenase

  2010cited by this paper
• Efficacy of topical cyclosporine A 2% in prevention of graft rejection in high-risk keratoplasty: a randomized controlled trial

  2010cited by this paper
• Prevention of Chronic Renal Allograft Rejection by Soluble CD83

  2010cited by this paper
• Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis.

  2010cited by this paper
• Immunosuppression Involving Soluble CD83 Induces Tolerogenic Dendritic Cells That Prevent Cardiac Allograft Rejection

  2010cited by this paper
• Dendritic cell physiology and function in the eye

  2010cited by this paper
• Efficacy of topical ciclosporin A for treatment and prevention of graft rejection in corneal grafts with previous rejection episodes

  2010cited by this paper
• Bioprocess development for production, purification, and structural characterization of recombinant hCD83ext as a potential therapeutic protein.

  2009cited by this paper
• Release and clinical significance of soluble CD83 in chronic lymphocytic leukemia.

  2009cited by this paper
• Cutting Edge: Lymphatic Vessels, Not Blood Vessels, Primarily Mediate Immune Rejections After Transplantation

  2009cited by this paper
• Engagement of CD83 on B Cells Modulates B Cell Function In Vivo1

  2009cited by this paper
• TGF-beta and kynurenines as the key to infectious tolerance.

  2009cited by this paper
• Levels of Foxp3 in Regulatory T Cells Reflect Their Functional Status in Transplantation1

  2009cited by this paper
• [Effect of TGF-beta1 on expression of integrin beta1 following corneal alkali burns in rabbits].

  2008cited by this paper
• Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease

  2008cited by this paper
• CD83 expression on dendritic cells and T cells: Correlation with effective immune responses

  2007cited by this paper
• IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-κB activation

  2007cited by this paper
• CD83 is a regulator of murine B cell function in vivo

  2007cited by this paper
• A limited course of soluble CD83 delays acute cellular rejection of MHC‐mismatched mouse skin allografts

  2007cited by this paper
• CD83 Knockdown in Monocyte-Derived Dendritic Cells by Small Interfering RNA Leads to a Diminished T Cell Stimulation1

  2007cited by this paper
• How Effective Is Penetrating Corneal Transplantation? Factors Influencing Long-Term Outcome in Multivariate Analysis

  2006cited by this paper
• Function of indoleamine 2,3‐dioxygenase in corneal allograft rejection and prolongation of allograft survival by over‐expression

  2006cited by this paper
• Influence of format on in vitro penetration of antibody fragments through porcine cornea

  2005cited by this paper
• Organ transplantation—how much of the promise has been realized?

  2005cited by this paper
• Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages.

  2005cited by this paper
• The impact of corneal allograft rejection on the long-term outcome of corneal transplantation.

  2005cited by this paper
• CD4+ T-Cell–Mediated Mechanisms of Corneal Allograft Rejection: Role of Fas-Induced Apoptosis

  2005cited by this paper
• Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival.

  2004cited by this paper
• Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity

  2004cited by this paper
• Ido expression by dendritic cells: tolerance and tryptophan catabolism

  2004cited by this paper
• Prevention and Treatment of Experimental Autoimmune Encephalomyelitis by Soluble CD83

  2004cited by this paper
• The soluble form of CD83 is present at elevated levels in a number of hematological malignancies.

  2004cited by this paper
• The good, the bad and the ugly--APCs of the eye.

  2003cited by this paper
• Role of Resident Corneal Leukocytes and Draining Cervical Lymph Nodes in Corneal Allograft Rejection

  2003cited by this paper
• Function of CD80 and CD86 on monocyte- and stem cell-derived dendritic cells.

  2003cited by this paper
• Tolerance, DCs and tryptophan: much ado about IDO.

  2003cited by this paper
• Rejection and recipient age.

  2002cited by this paper
• Vaccines: Spinning molecular immunology into successful immunotherapy

  2002cited by this paper
• Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells.

  2002cited by this paper
• Overexpression, purification, and biochemical characterization of the extracellular human CD83 domain and generation of monoclonal antibodies.

  2002cited by this paper
• Cutting Edge: CD83 Regulates the Development of Cellular Immunity1

  2002cited by this paper
• Kinetics of leukocyte and myeloid cell traffic in the murine corneal allograft response.

  2001cited by this paper
• The Extracellular Domain of CD83 Inhibits Dendritic Cell–mediated T Cell Stimulation and Binds to a Ligand on Dendritic Cells

  2001cited by this paper
• A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera.

  2001cited by this paper
• Ocular complications of topical, peri-ocular, and systemic corticosteroids

  2000cited by this paper
• Cloning, recombinant expression and biochemical characterization of the murine CD83 molecule which is specifically upregulated during dendritic cell maturation

  1999cited by this paper
• An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

  1999cited by this paper
• The mouse Cd83 gene: structure, domain organization, and chromosome localization

  1998cited by this paper
• Prevention of allogeneic fetal rejection by tryptophan catabolism.

  1998cited by this paper
• Cytokine mRNA expression during experimental corneal allograft rejection.

  1996cited by this paper
• Immunosuppression in corneal transplantation

  1995cited by this paper
• Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen

  1994cited by this paper

• No citing papers are available for this paper.